Manufacturer of Controlled Substances; Notice of Registration, 10681 [05-4232]

Download as PDF 10681 Federal Register / Vol. 70, No. 42 / Friday, March 4, 2005 / Notices Dated: February 23, 2005. William J. Walker, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 05–4200 Filed 3–3–05; 8:45 am] Dated: February 22, 2005. William J. Walker, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 05–4231 Filed 3–3–05; 8:45 am] Dated: February 22, 2005. William J. Walker, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 05–4232 Filed 3–3–05; 8:45 am] BILLING CODE 4410–09–P BILLING CODE 4410–09–P BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE Drug Enforcement Administration Drug Enforcement Administration Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration Manufacturer of Controlled Substances; Notice of Registration By notice dated October 18, 2004, and published in the Federal Register on October 25, 2004, (69 FR 62295), National Center for Development of Natural Products, The University of Mississippi, 135 Coy Waller Lab Complex, University, Mississippi 38677, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in Schedule I: By notice dated October 18, 2004, and published in the Federal Register on October 25, 2004, (69 FR 62295), National Center for Natural Products Research— NIDA MProject, University of Mississippi, 135 Coy Waller Lab Complex, University, Mississippi 38677, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in Schedule I: Drug Marihuana (7360) ......................... Tetrahydrocannabinols (7370) ...... 20:07 Mar 03, 2005 Jkt 205001 Schedule Marihuana (7360) ......................... Tetrahydrocannabinols (7370) ...... I I The company plans to manufacture the controlled substances in bulk for product development. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of National Center for Development of Natural Products to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated National Center for Development of Natural Products to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. VerDate jul<14>2003 Drug Schedule I I The company plans to cultivate marihuana for the National Institute of Drug Abuse for research approved by the Department of Health and Human Services. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of National Center for Natural Products Research—NIDA MProject, University of Mississippi to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated National Center for Natural Products Research— NIDA MProject, University of Mississippi to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. PO 00000 Frm 00091 Fmt 4703 Sfmt 4703 Importation of Controlled Substances; Notice of Application Pursuant to 21 U.S.C. 958(1), the Attorney General shall, prior to issuing a registration under this Section to a bulk manufacturer of a controlled substance in Schedule I or II and prior to issuing a regulation under 21 U.S.C. 952(a)(2)(b) authorizing the importation of such substances, provide manufacturers holding registrations for the bulk manufacture of the substances an opportunity for a hearing. Therefore, in accordance with 21 CFR 1301.34(a), this is notice that on October 4, 2004, Noramco Inc., 500 Old Swedes Landing Road, Wilmington, Delaware 19801, made application by renewal to the Drug Enforcement Administration (DEA) for registration as an importer of the basic class of controlled substances listed in Schedule II: Drug Raw Opium (9600) ....................... Concentrate of Poppy Straw (9670). Schedule II II The company plans to import the listed controlled substances to manufacture other controlled substances. Any manufacturer who is presently, or is applying to be, registered with DEA to manufacture such basic classes of controlled substances may file written comments or objections to the issuance of the proposed registration and may, at the same time, file a written request for a hearing on such application pursuant to 21 CFR 1301.43 and in such form as prescribed by 21 CFR 1316.47. Any such written comments or objections being sent via regular mail may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, Washington, DC 20537, Attention: DEA Federal Register Representative, Liaison and Policy Section (ODL); or any being sent via express mail should be sent to DEA Headquarters, Attention: DEA Federal Register Representative/ODL, 2401 Jefferson-Davis Highway, E:\FR\FM\04MRN1.SGM 04MRN1

Agencies

[Federal Register Volume 70, Number 42 (Friday, March 4, 2005)]
[Notices]
[Page 10681]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-4232]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By notice dated October 18, 2004, and published in the Federal 
Register on October 25, 2004, (69 FR 62295), National Center for 
Natural Products Research-- NIDA MProject, University of Mississippi, 
135 Coy Waller Lab Complex, University, Mississippi 38677, made 
application by renewal to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of the basic classes of controlled 
substances listed in Schedule I:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Marihuana (7360)............................  I
Tetrahydrocannabinols (7370)................  I
------------------------------------------------------------------------

    The company plans to cultivate marihuana for the National Institute 
of Drug Abuse for research approved by the Department of Health and 
Human Services.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
National Center for Natural Products Research--NIDA MProject, 
University of Mississippi to manufacture the listed basic classes of 
controlled substances is consistent with the public interest at this 
time. DEA has investigated National Center for Natural Products 
Research--NIDA MProject, University of Mississippi to ensure that the 
company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 
21 CFR 1301.33, the above named company is granted registration as a 
bulk manufacturer of the basic classes of controlled substances listed.

    Dated: February 22, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 05-4232 Filed 3-3-05; 8:45 am]
BILLING CODE 4410-09-P